Ë¿¹ÏÊÓƵAPP

In uncertain times, the certainty of statistics can seem like a balm, but is the concept of statistical significance misunderstood — and misused? In an issue of the Society of Actuaries' publication Predictive Analytics and Futurism, Ë¿¹ÏÊÓƵAPP's Rosmery ...

Read More

Claims professionals can benefit from a greater understanding of the role and efficacy of radiosurgery, particularly when used for conditions with complex neurological causes and in cases that might formerly have been deemed untreatable.

Read More

Pressure continues to build on maximum underwriting guidelines for group life and group long-term disability (LTD) policies in employee benefit plans in the small case marketplace (i.e., employers with <200 lives). This paper discusses causes and consequenc... Read More

The development of new and innovative products is a key success factor for insurers. One such product is Cancer Reimbursement insurance. This article will address aspects of this product’s development journey. Read More

The clinical understanding and treatment of chronic lymphocytic leukemia (CLL), the most prevalent adult leukemia in the West, has experienced several advances over the past decade. This article examines these advances and prognostic implications for insurers... Read More

Review the role of genetics in chronic lymphocytic leukemia and explore Cancer Reimbursement products.
Read More

Will consumer behavior change as genetic testing becomes more accessible? Read More

Genomic tests and their outcomes are creating important considerations for insurers – especially in underwriting and claims. Read More

What are the underwriting implications of democratising health records and are underwriters ready? Read More

Explaining a claims decision, a specific policy clause or simply requesting additional information can create confusion and frustration for the claimant if not done clearly. Here are some simple suggestions. 

Read More

This article examines some of suicide’s impact on the U.S. life insurance industry, and also briefly looks at current practices and thoughts regarding suicide prevention. Read More

Annuities can provide a guaranteed fixed income for life in exchange for a lump-sum payment, making them a good way to meet the first two needs. This article will discuss the growth and development of the U.K.’s enhanced annuity market, the recent legislative changes re... Read More

This article was developed with the support of Ë¿¹ÏÊÓƵAPP Australia and New Zealand and the Ë¿¹ÏÊÓƵAPP Hong Kong, Korea and Japan offices and addresses cancer products throughout Asia.  Read More

This article explores the opportunity to revolutionise financial services for mass emerging markets through microinsurance.   Read More

The expanding presence of Zika virus in Brazil and Latin America and its recent incursion into North America demonstrate the changeable and unpredictable risks posed by infectious diseases. Read More

The pre-existing condition (PEC) exclusion clause, long a staple of health insurance underwriting, has undergone a measure of change; this brief reviews PEC language and governance. 

Read More

Three-quarters of all cervical cancers are known to be caused by two types of human papillomavirus – HPV 16 and 183.  This article will look at assessment factors that need to be considered in product development, underwriting and clai...

Read More

Explore the history and intricacies of Critical Illness (CI) product development. CI definitions must be well-worded with clear claims triggers and kept current with medical science.  Read More

This article explores how the underwriter's perspective can benefit the group product development process.

Read More

Learn more about the intricacies of Critical Illness (CI) product development and review cervical cancer.
Read More